Method for purification of interferon-beta protein with 2 glycosylation sites
KR20180108550A
Monoclonal Antibodies Specific to Claudin 3 and 4, and The Use Thereof
KR20200012223A
Markers of differentiation potency of chondrocyte
KR20190028903A
Composition for Modified release capsule containing triazolopyrazine derivatives compounds, binder and disintegrant
CN109890844A
Anti- NINJ-1 antibody and application thereof
KR20180092523A
Serum-free medium additive composition and method for inducing chondrogenesis of mesenchymal stem cells
KR20180092096A
Novel Polymorphic Forms of Triazolopyrazine Derivatives and Processes of Manufacturing Thereof
KR20180038290A
Stabilized Formulations of Interferon beta Mutant
KR20180025743A
Immunocytokine conjugated with human interferon beta-mutein and method for preparing thereof
KR20170124728A
Reagent for detecting cross contamination of PDX-model related with human and mouse, the kit comprising the same, and the method for the cross contamination detection
KR20170139055A
Methods for maintaining increased intracellular p53 levels induced by platinum-based anticancer agents and their use
WO2016163764A2
Stabilized preparation of interferon beta variant
KR20160120239A
Stabilized Formulations of Interferon beta Mutant
US2017209588A1
Pegylated interferon-beta variant
KR20160133293A
Sensitizing composition for cancer comprising an agent inhibiting expression of oncogenes of HPV virus
KR20160127601A
Dendron conjugated antibody and use thereof
KR20160107070A
Immunocytokine conjugated with human interferon beta-mutein and method for preparing thereof
KR20160104160A
Monoclonal Antibodies Specific to Claudin 3 and 4, and The Use Thereof
WO2016013697A1
Polyethylene glycol complex of interferon-beta variant
EP3346403A1
Data processing, analysis method of gene expression data to identify endogenous reference genes
